MONITORING OF GENE EXPRESSION IN TACROLIMUS-TREATED DE NOVO RENAL ALLOGRAFT RECIPIENTS FACILITATES INDIVIDUALIZED IMMUNOSUPPRESSION - RESULTS OF THE IMAGEN STUDY

被引：0
|
作者：
Sommerer, C. [1 ]
Millan, O. [2 ]
Glander, P. [3 ]
Brunet, M. [2 ]
Guirado Perich, L. [4 ]
Budde, K. [3 ]
Meuer, S. [5 ]
Zeier, M. [1 ]
Giese, T. [5 ]
机构：
[1] Univ Hosp Heidelberg, Nephrol, Heidelberg, Germany
[2] Hosp Clin Barcelona, Pharmacol & Toxicol Lab, Barcelona, Spain
[3] Charite, Nephrol, Berlin, Germany
[4] Fundacio Puigvert Barcelona, Renal Transplant Unit, Barcelona, Spain
[5] Univ Hosp Heidelberg, Immunol, Heidelberg, Germany
来源：
TRANSPLANT INTERNATIONAL | 2020年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
S24-03
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [31] 12 MONTHS OUTCOMES ON ALLOGRAFT FUNCTION WITH EVEROLIMUS-CNI VS TACROLIMUS-MPA REGIMEN IN DE NOVO RENAL TRANSPLANT RECIPIENTS: THE ATHENA STUDY
    Merville, P.
    Kamar, N.
    Dragun, D.
    Sommerer, C.
    Suwelack, B.
    Schenker, P.
    Hauser, I. A.
    Witzke, O.
    Hugo, C.
    Junge, M.
    Thaiss, F.
    Nashan, B.
    TRANSPLANT INTERNATIONAL, 2018, 31 : 15 - 15
  • [32] Calcineurin Inhibitor Free De Novo Immunosuppression in Liver Transplant Recipients With Pretransplant Renal Impairment: Results of a Pilot Study (PATRON07)
    Schnitzbauer, Andreas A.
    Sothmann, Johannes
    Baier, Lucia
    Bein, Thomas
    Geissler, Edward K.
    Scherer, Marcus N.
    Schlitt, Hans J.
    TRANSPLANTATION, 2015, 99 (12) : 2565 - 2575
  • [33] Outcomes on Allograft Function after 12 Months with Everolimus Plus either Tacrolimus or Cyclosporine Compared to a Standard Tacrolimus-MPA Regimen in De Novo Renal Transplant Recipients: The Athena Study
    Schenker, Peter
    Sommerer, Claudia
    Suwelack, Barbara
    Dragun, Duska
    Hauser, Ingeborg A.
    Witzke, Oliver
    Hugo, Christian
    Kamar, Nassim
    Merville, Pierre
    Junge, Martina
    Thaiss, Friedrich
    Nashan, Bjoern
    TRANSPLANTATION, 2018, 102 : S280 - S280
  • [34] Clinical efficacy and toxicity profile of tacrolimus and mycophenolic acid in relation to combined long-term pharmacolunetics in de novo renal allograft recipients
    Kuypers, DRJ
    Claes, K
    Evenepoel, P
    Maes, B
    Vanrenterghem, Y
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (05) : 434 - 447
  • [35] A Randomized, Open-Label Study of Sirolimus Versus Cyclosporine in Primary De Novo Renal Allograft Recipients
    Flechner, Stuart M.
    Gurkan, Alihan
    Hartmann, Anders
    Legendre, Christophe M.
    Russ, Graeme R.
    Campistol, Josep M.
    Schena, Francesco P.
    Hahn, Carolyn M.
    Li, Huihua
    Korth-Bradley, Joan M.
    Tai, Sandi See
    Schulman, Seth L.
    TRANSPLANTATION, 2013, 95 (10) : 1233 - 1241
  • [36] Long-term efficacy and safety of steroid-withdrawal in tacrolimus-treated renal transplant recipients: Results of a 3-year follow-up.
    Pascual, J
    van Hooff, JP
    Salmela, K
    Klemens, B
    Paolo, R
    Philippe, L
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 576 - 577
  • [37] ATHENA STUDY OUTCOMES ON ALLOGRAFT FUNCTION AFTER 12 MONTHS WITH EVEROLIMUS-CNI VS TACROLIMUS-MPA REGIMEN IN DE NOVO RENAL TRANSPLANT RECIPIENTS
    Dragun, Duska
    Sommerer, Claudia
    Suwelack, Barbara
    Schenker, Peter
    Hauser, Ingeborg
    Witzke, Oliver
    Hugo, Christian
    Kamar, Nassim
    Merville, Pierre
    Junge, Martina
    Thaiss, Friedrich
    Nashan, Bjoern
    TRANSPLANT INTERNATIONAL, 2017, 30 : 562 - 562
  • [38] A PROSPECTIVE TRIAL OF DIET AND EXERCISE TO IMPROVE GLUCOSE METABOLISM AND CARDIOVASCULAR RISK FOR DE NOVO KIDNEY TRANSPLANT RECIPIENTS TREATED WITH TACROLIMUS-BASED IMMUNOSUPPRESSION
    Steven, Chadban
    Georgia, Whitman
    Kate, Wyburn
    Belinda, Butcher
    Tara, Rees
    Graeme, Russ
    William, Mulley
    Ashley, Irish
    David, Dunstan
    Josette, Eris
    IMMUNOLOGY AND CELL BIOLOGY, 2013, 91 (08): : A35 - A36
  • [39] A PROSPECTIVE TRIAL OF DIET AND EXERCISE TO IMPROVE GLUCOSE METABOLISM AND CARDIOVASCULAR RISK FOR DE NOVO KIDNEY TRANSPLANT RECIPIENTS TREATED WITH TACROLIMUS-BASED IMMUNOSUPPRESSION
    Chadban, S.
    Whitman, G.
    Wyburn, K.
    Butcher, B.
    Rees, T.
    Russ, G.
    Mulley, W.
    Irish, A.
    Dunstan, D.
    Eris, J.
    NEPHROLOGY, 2012, 17 : 70 - 70
  • [40] Individualized Monitoring of NFAT-Regulated Gene Expression in FK506 Treated Kidney Transplant Recipients
    Sommerer, Claudia
    Giese, Thomas
    Meuer, Stefan
    Zeier, Martin
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 507 - 507
12345